STOCK TITAN

Datametrex Ai Li Stock Price, News & Analysis

DTMXF OTC

Welcome to our dedicated page for Datametrex Ai Li news (Ticker: DTMXF), a resource for investors and traders seeking the latest updates and insights on Datametrex Ai Li stock.

Datametrex Ai Li (DTMXF) delivers innovative AI solutions across healthcare and technology sectors through strategic partnerships and operational excellence. This news hub provides verified updates on corporate developments, financial milestones, and technological advancements essential for informed analysis.

Access real-time updates on earnings reports, AI implementation progress, healthcare system integrations, and strategic restructuring efforts. Our curated news collection serves investors and industry observers with:

• AI deployment timelines in clinical settings
• IT service expansion in key global markets
• Partnership announcements with healthcare providers
• Financial performance updates and strategic pivots

Bookmark this page for vetted information on DTMXF's progress in merging artificial intelligence with practical healthcare solutions and enterprise IT services. Regular updates ensure you maintain current awareness of the company's market positioning and technological roadmap.

Rhea-AI Summary

Datametrex (OTC:DTMXF) completed the acquisition of the Yuzu payment processing solution from Firstpayment via subsidiary Paymetrex on December 19, 2025. The purchase price was $5.5 million, satisfied by issuance of 55,000,000 common shares at a deemed price of $0.10 per share, subject to a four-month-and-one-day hold period.

The company did not assume Firstpayment debt. Proceeds from a prior private placement were released from escrow to fund integration of Yuzu and merchant commercialization efforts. Michael Kron was appointed to the board and now holds approximately 12.15% of outstanding common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.5%
Tags
-
Rhea-AI Summary

Datametrex (OTC:DTMXF) signed a definitive asset purchase agreement dated December 9, 2025 to acquire the Yuzu payment processing solution, including related patents and intellectual property, from Firstpayment for a purchase price of $5.5 million.

The purchase price will be satisfied by issuing 55,000,000 common shares at a deemed price of $0.10 per share to Firstpayment. Completion is expected on or about December 17, 2025, subject to customary closing conditions and TSXV approval.

Upon closing, proceeds from a previously announced private placement will be released from escrow to integrate Yuzu into Datametrex's technology division and pursue merchant revenue opportunities; Michael Kron is expected to join the board and serve as COO of Paymetrex.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Datametrex (OTC:DTMXF) announced on December 1, 2025 that its wholly owned subsidiary Imagine Health has launched walk-in services at Calgary and Edmonton clinics, and is accepting new family patients.

Both clinics operate Monday to Friday, 8:30 AM–4:30 PM, and will treat same-day, non-emergency needs including respiratory infections, minor injuries, urgent prescriptions, and chronic condition flare-ups. Locations, phone numbers, and clinic hours are provided for patient access.

The company said the expansion advances its goal of improving timely, patient-focused care across Western Canada and signals continued exploration of broader clinic network growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.16%
Tags
none
Rhea-AI Summary

Datametrex (OTC:DTMXF) announced on November 27, 2025 that its subsidiary Datametrex Korea secured purchase orders totaling approximately CAD $650,000. The P.O.s represent roughly CAD $650,000 in new revenue with an approximate 20% gross profit margin. The company described the orders as part of its land and expand strategy and said they reinforce its role as an IT infrastructure solutions provider to major global partners.

The announcement highlights contribution from Korean operations and management commentary emphasizing continued partnership-driven growth and operational execution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Datametrex AI (OTC:DTMXF) announced that its wholly owned subsidiary Imagine Health added four new physicians and is accepting new patients in Calgary and Edmonton as of November 24, 2025.

Calgary clinics added Dr. Younis, Dr. Rezaeisarlak, and Dr. Fiselier to expand insured primary-care services under Alberta's provincial system. Edmonton clinic added Dr. Abdulkadir to increase capacity and access. The release lists clinic addresses, phone numbers, fax numbers, and Monday–Friday hours for booking appointments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.71%
Tags
none
-
Rhea-AI Summary

DataMetrex (OTC:DTMXF) announced that subsidiary Imagine Health Medical Clinics has reopened its Edmonton South clinic at 2551 Hewes Way NW, Suite 104, Edmonton, AB T6L 6W6. The new facility is open and accepting new patients seeking a family physician.

Clinic contact: (780) 468-5999, fax 1 (855) 751-0323. Hours: Monday–Friday, 8:30 AM–4:30 PM. Management said the relocation provides a modern, accessible space intended to support patient-focused care across Alberta.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.22%
Tags
none
Rhea-AI Summary

Datametrex AI (OTC:DTMXF) announced that its wholly owned subsidiary Imagine Health Medical Clinics has relocated its Calgary clinic to Capitol Hill and is now fully operational.

New address: 2004 14 Street NW, Suite 207, Calgary, Alberta T2M 3N3. Clinic hours are Monday–Friday, 8:30 AM–4:30 PM. Contact: (403) 775-9669 or fax 1 (866) 483-1816. The clinic is accepting new patients and bookings by phone or fax.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
42.86%
Tags
none
-
Rhea-AI Summary

Datametrex (OTC:DTMXF) closed two financings on November 14, 2025, raising aggregate gross proceeds of $5,133,500 through a common share private placement (47,918,750 shares at $0.08; $3,833,500) and a subscription receipt financing (16,250,000 receipts at $0.08; $1,300,000).

The subscription proceeds are escrowed pending satisfaction of escrow release conditions tied to the proposed acquisition of the Yuzu Payment Solution, with an escrow release deadline of December 31, 2025. Proceeds will fund Yuzu integration, merchant opportunities, a new clinic location, and working capital. Finders fees total $130,000 cash plus 1,625,000 finders warrants for the subscription financing and cash and equity finders fees for the common placement. Insider Andrew Ryu acquired 16,250,000 shares (~16.65%).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.22%
Tags
none
-
Rhea-AI Summary

Datametrex AI (TSXV:DM / FSE:D4G / OTC:DTMXF) announced it intends to close two financings on November 14, 2025: a non-brokered private placement and a subscription receipt financing.

The company plans to issue up to 50,000,000 common shares at $0.08 for gross proceeds up to $4,000,000, and up to 16,250,000 subscription receipts at $0.08 for gross proceeds up to $1,300,000, totaling up to $5,300,000 in gross proceeds.

Net proceeds are designated for business expansion, a new location, integration of the Yuzu Payment Solution into Datametrex's technology division, and general working capital. The company may pay finder's fees up to 5% cash, 5% shares and 10% warrants or alternatively up to 10% cash and 10% warrants. All securities will be subject to a statutory hold period of four months plus one day.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Datametrex AI (OTC:DTMXF) announced the immediate appointment of Mr. Enrico Moretti to its Board of Directors, effective October 24, 2025. Mr. Moretti is a securities lawyer with cross-border experience (called to the Ohio bar in 1997 and Ontario bar in 2000) and specializes in corporate and securities law, corporate finance transactions, governance, and regulatory compliance.

The appointment fulfills the Exchange's minimum director requirement and follows a trading halt the Exchange imposed while the company remedied the board deficiency. The company said it acted promptly, has notified the Exchange, and is working to restore normal trading and confirm continued listing compliance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.05%
Tags
none

FAQ

What is the current stock price of Datametrex Ai Li (DTMXF)?

The current stock price of Datametrex Ai Li (DTMXF) is $0.0963 as of December 26, 2025.

What is the market cap of Datametrex Ai Li (DTMXF)?

The market cap of Datametrex Ai Li (DTMXF) is approximately 1.3M.
Datametrex Ai Li

OTC:DTMXF

DTMXF Rankings

DTMXF Stock Data

1.28M
76.32M
2.04%
Information Technology Services
Technology
Link
Canada
Toronto